Financials
Financial year 2025
FILI-PHARMA from Ninove, company number BE0822645914, closed financial year 2025 with a result of € 140,905 after tax. For that financial year FILI-PHARMA recorded a gross margin of € 102,643 and equity of € 968,090. Compared with financial year 2024, the result moved from € 168,414 to € 140,905. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 29, 2026.
€ 968,090
▲ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 140,905
▼ 16% vs 2024
Profit after tax over the fiscal year.
€ 339,641
▼ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 918,090.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 24,430
▼ 45% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 100,793 | € 99,540 | € 101,242 | € 102,643 | ▲ 1% |
| Profit after taxes | € 65,728 | € 62,083 | € 168,414 | € 140,905 | ▼ 16% |
| Equity | € 596,687 | € 658,770 | € 827,184 | € 968,090 | ▲ 17% |
| Total debts | € 251,003 | € 261,309 | € 289,685 | € 273,254 | ▼ 6% |
| Cash | € 133,684 | € 192,911 | € 425,076 | € 339,641 | ▼ 20% |
| Land & buildings | - | - | - | € 190,766 | |
| Retained profit | € 546,687 | € 608,770 | € 777,184 | € 918,090 | ▲ 18% |
| Balance sheet total | € 847,690 | € 920,079 | € 1,116,869 | € 1,241,344 | ▲ 11% |
By gross margin, FILI-PHARMA ranks 6th of 11 companies with main activity “Verhuur en lease van medisch en paramedisch materieel” in East Flanders that publish figures (fiscal year 2025).
Key figures of FILI-PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about FILI-PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to FILI-PHARMA?
What happened at FILI-PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 140,905 (▼ 16% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- Filip Van der Elst became a director. NBB
- New establishment in Ninove. KBO
In short
From € 65,728 profit in 2022 to € 140,905 profit in 2025.
Paid € 111,451 in corporate taxes since 2022.
Best year ever: 2024, with € 168,414 profit.
Management
Behind FILI-PHARMA is Filip Van der Elst. It owns 100% of Apotheek Van Der Elst Filip itself.
Directors
According to the 2025 annual accounts
Filip Van der Elst
Director
since 2010
Establishments
Establishment units
Physical locations of this company
Smid Lambrechtstraat 70
9406 Ninove
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in East Flanders
Same main activity (Verhuur en lease van medisch en paramedisch materieel), 16 active companies in East Flanders, largest first.
€ 1.4 million gross margin · 2025 · Aalst
Zorg en Meer Oost-Vlaanderen vzw
€ 1.2 million gross margin · 2025 · Gent
€ 486,409 gross margin · 2025 · Destelbergen
€ 173,947 gross margin · 2025 · Destelbergen
€ 156,045 gross margin · 2025 · Merelbeke-Melle
€ 70,686 gross margin · 2025 · Gent
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VAN der ELST Filip Roger Jozef(oprichter) 100%
Details
- Company number
- 0822.645.914
- VAT number
- BE 0822.645.914
- Registered office
- Smid Lambrechtstraat 70, 9406 Ninove
- Names & denominations
- FILI-PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 January 2010
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Verhuur en lease van medisch en paramedisch materieel
Detailhandel in farmaceutische producten
Vervaardiging van overige farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Groothandel in parfumerieën en cosmetica
Vervaardiging van farmaceutische grondstoffen